ID

15404

Description

FUSION I Assesses Safety and Tolerability of Two Doses of NATRECOR (Nesiritide) Administered to Patients With Worsening Congestive (Decompensated) Heart Failure Who Are Concurrently Receiving Their Usual Cardiac Medications and Are at High Risk for Hospitalization.; ODM derived from: https://clinicaltrials.gov/show/NCT00270361

Lien

https://clinicaltrials.gov/show/NCT00270361

Mots-clés

  1. 30/05/2016 30/05/2016 -
Téléchargé le

30 mai 2016

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :


Aucun commentaire

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Heart Failure, Congestive NCT00270361

Eligibility Heart Failure, Congestive NCT00270361

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
subjects having had at least two hospital admissions (or equivalent treatment) for acutely decompensated chf within the last 12 months, with at least one of these admissions in the past 30 days, and having received treatment with intravenous vasoactive agents (such as intravenous inotropes, natrecor®, or nitroglycerin)
Description

congestive heart failure; therapeutic procedure

Type de données

boolean

Alias
UMLS CUI [1]
C0018802
UMLS CUI [2]
C0087111
able to be enrolled and initiate treatment with study drug within 5 to 30 days of last hospital discharge (or equivalent treatment) of acutely decompensated chf
Description

congestive heart failure, decompensated, recent

Type de données

boolean

Alias
UMLS CUI [1,1]
C0018802
UMLS CUI [1,2]
C0205434
UMLS CUI [1,3]
C0332185
have a baseline nyha (new york heart association) functional classification iii or iv for at least 2 months prior to randomization
Description

nyha

Type de données

boolean

Alias
UMLS CUI [1]
C1275491
currently receiving optimal treatment with long term oral medications (e.g., diuretics, ace inhibitors, and beta blockers, unless beta blockers or ace inhibitors are documented to be contraindicated or not tolerated)
Description

oral medication

Type de données

boolean

Alias
UMLS CUI [1]
C0175795
willing to receive infusions of natrecor®, or possibly other medications, at least as frequently as once per week for 12 weeks.
Description

informed consent

Type de données

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
subjects having systolic blood pressure consistently less than 90 mm hg
Description

systolic blood pressure

Type de données

boolean

Alias
UMLS CUI [1]
C0871470
having had organ transplantation (heart, liver, lung and kidney) in the past or anticipating organ transplantation during the study
Description

organ transplantation

Type de données

boolean

Alias
UMLS CUI [1]
C0029216
not able or willing to discontinue intermittent or continuous infusions of inotropes if randomized to a natrecor® treatment group
Description

informed consent, inotropes

Type de données

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C0304509
having had a bi-ventricular pacemaker placed within the past 60 days or an automatic implantable cardiac defibrillator placed within the past 30 days
Description

biventricular pacemaker

Type de données

boolean

Alias
UMLS CUI [1]
C1719274
UMLS CUI [2]
C0162589
requiring chronic dialysis or have an expectation that dialysis will be required during the course of the study.
Description

dialysis

Type de données

boolean

Alias
UMLS CUI [1]
C0011946

Similar models

Eligibility Heart Failure, Congestive NCT00270361

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
congestive heart failure; therapeutic procedure
Item
subjects having had at least two hospital admissions (or equivalent treatment) for acutely decompensated chf within the last 12 months, with at least one of these admissions in the past 30 days, and having received treatment with intravenous vasoactive agents (such as intravenous inotropes, natrecor®, or nitroglycerin)
boolean
C0018802 (UMLS CUI [1])
C0087111 (UMLS CUI [2])
congestive heart failure, decompensated, recent
Item
able to be enrolled and initiate treatment with study drug within 5 to 30 days of last hospital discharge (or equivalent treatment) of acutely decompensated chf
boolean
C0018802 (UMLS CUI [1,1])
C0205434 (UMLS CUI [1,2])
C0332185 (UMLS CUI [1,3])
nyha
Item
have a baseline nyha (new york heart association) functional classification iii or iv for at least 2 months prior to randomization
boolean
C1275491 (UMLS CUI [1])
oral medication
Item
currently receiving optimal treatment with long term oral medications (e.g., diuretics, ace inhibitors, and beta blockers, unless beta blockers or ace inhibitors are documented to be contraindicated or not tolerated)
boolean
C0175795 (UMLS CUI [1])
informed consent
Item
willing to receive infusions of natrecor®, or possibly other medications, at least as frequently as once per week for 12 weeks.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
systolic blood pressure
Item
subjects having systolic blood pressure consistently less than 90 mm hg
boolean
C0871470 (UMLS CUI [1])
organ transplantation
Item
having had organ transplantation (heart, liver, lung and kidney) in the past or anticipating organ transplantation during the study
boolean
C0029216 (UMLS CUI [1])
informed consent, inotropes
Item
not able or willing to discontinue intermittent or continuous infusions of inotropes if randomized to a natrecor® treatment group
boolean
C0021430 (UMLS CUI [1,1])
C0304509 (UMLS CUI [1,2])
biventricular pacemaker
Item
having had a bi-ventricular pacemaker placed within the past 60 days or an automatic implantable cardiac defibrillator placed within the past 30 days
boolean
C1719274 (UMLS CUI [1])
C0162589 (UMLS CUI [2])
dialysis
Item
requiring chronic dialysis or have an expectation that dialysis will be required during the course of the study.
boolean
C0011946 (UMLS CUI [1])

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial